LEXARIA BIOSCIENCE CORP. License and Services Revenue (Deprecated 2018-01-31)
LEXARIA BIOSCIENCE CORP. (LEXX) reported License and Services Revenue (Deprecated 2018-01-31) of $321.68 thousand for the 9-month period ending 2018-05-31, per its 10-Q filed 2018-07-13.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2018-07-13
- LEXARIA BIOSCIENCE CORP. license and services revenue (deprecated 2018-01-31) for the quarter ending 2018-05-31 was $137.60K, a 625.70% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. license and services revenue (deprecated 2018-01-31) for the quarter ending 2018-02-28 was $167.83K, a 1548.49% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-11-30 was $16.25K, a 96.97% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-05-31 was $18.96K.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2018-05-31 | $137.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $305.43K derived: sum of 2 quarters · filed 2018-07-13 | $321.68K 10-Q · filed 2018-07-13 |
| 2018-02-28 | $167.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $184.08K 10-Q · filed 2018-04-12 | |
| 2017-11-30 | $16.25K 10-Q · filed 2018-01-12 | ||
| 2017-05-31 | $18.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $29.14K derived: sum of 2 quarters · filed 2018-07-13 | $37.39K 10-Q · filed 2018-07-13 |
| 2017-02-28 | $10.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $18.43K 10-Q · filed 2018-04-12 | |
| 2016-11-30 | $8.25K 10-Q · filed 2018-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |